Analytical Research & Development (AR&D) Division firmly reinforces the mission and vision of IPC by bringing highest standards of drugs through its translational and dynamic research activities. AR&D division continuously promulgate changes to analytical test procedures according to the latest technological requirements.

Analytical R&D division has the following capabilities:

1. The division is actively engaged in development of new monographs & revision/ up gradation of existing monographs of APIs, formulations & fixed-dose combinations for Indian Pharmacopoeia for ensuring quality control of drugs and medicines used by Indian Population.

2. The division also brings Errata and Amendment lists as and when required based on the queries / suggestions from the stakeholders / or experts.

3. Acts as IPC Secretariat and develops monographs and resolves queries by working closely with marketing authorization holder’s (MAHs), other international pharmacopoeias and with stakeholders of IP.

4. Method development and validation of new methodologies / Upgradation for Indian Pharmacopoeia.

5. Method development and validation of new monographs and for publication in national and International Journals.

6. Actively involved in collaboration / harmonization activities with other international Pharmacopoeias such as USP, BP, EP, and International Pharmacopoeia WHO.

7. Up gradation of monographs, general Chapters as per latest technological requirements for assuring quality of drugs marketing in India.

8. Coordinating meetings of various Expert Working groups for development and upgradation of Indian Pharmacopoeia

9. Dissemination and integration of research knowledge by involving in research activities and projects.

10. Provide review and comments on Standards under development of BIS and WHO (International Pharmacopoeia)

11. Impart training to pharma graduates/ post graduates/ Scientists with a view to create awareness and impart skills.